Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M802205200 on May 6, 2008

J. Biol. Chem., Vol. 283, Issue 27, 18627-18635, July 4, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/27/18627    most recent
M802205200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toso, R.
Right arrow Articles by Camire, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toso, R.
Right arrow Articles by Camire, R. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Conformational Switch from the Factor X Zymogen to Protease State Mediates Exosite Expression and Prothrombinase Assembly*

Raffaella Toso{ddagger}, Hua Zhu{ddagger}, and Rodney M. Camire{ddagger}§1

From the {ddagger}Department of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia and §University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104

Zymogens of the chymotrypsin-like serine protease family are converted to the protease state following insertion of a newly formed, highly conserved N terminus. This transition is accompanied by active site formation and ordering of several surface loops in the catalytic domain. Here we show that disruption of this transition in factor X through mutagenesis (FXaI16L and FXaV17A) not only alters active site function, but also significantly impairs Na+ and factor Va binding. Active site binding was improved in the presence of high NaCl or with saturating amounts of factor Va membranes, suggesting that allosteric linkage exists between these sites. In line with this, irreversible stabilization of FXaI16L with Glu-Gly-Arg-chloromethyl ketone fully rescued FVa binding. Furthermore, the Km for prothrombin conversion with the factor Xa variants assembled into prothrombinase was unaltered, whereas the kcat was modestly reduced (3- to 4-fold). These findings show that intramolecular activation of factor X following the zymogen to protease transition not only drives catalytic site activation but also contributes to the formation of the Na+ and factor Va binding sites. This structural plasticity of the catalytic domain plays a key role in the regulation of exosite expression and prothrombinase assembly.


Received for publication, March 19, 2008 , and in revised form, April 8, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL-74124-01, Project 2 (to R. M. C.). This work was also supported by National Research Service Award T32 HL-07439-26 (to R. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Division of Hematology, 302E Abramson Research Center, The Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104. Tel.: 215-590-9968; Fax: 215-590-3660; E-mail: rcamire{at}mail.med.upenn.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
M. H. A. Bos, M. Boltz, L. St. Pierre, P. P. Masci, J. de Jersey, M. F. Lavin, and R. M. Camire
Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations
Blood, July 16, 2009; 114(3): 686 - 692.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
L. Ivanciu, R. Toso, A. Schlachterman, H. Downey, J.-H. Liu, V. R. Arruda, and R. M. Camire
Factor Xa Variants as Novel Bypass Agents for the Treatment of Hemophilia in Murine Models
Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 239 - 239.
[Abstract]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
M. W Bunce, R. Toso, V. R. Arruda, and R. M. Camire
Zymogen-Like Factor Xa Variants Restore Thrombin Generation and Effectively Bypass the Intrinsic Pathway in Vitro
Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 240 - 240.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement